Enpp-1-IN-5
Enpp-1-IN-5 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) . The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-5 has the potential for the research of cancer and infectious diseases (extracted from patent WO2019046778A1/WO2021203772A1, compound 1) [1][2].
Product Specifications
CAS Number
2230916-95-5
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/enpp-1-in-5.html
Purity
98.16
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(N)(NCCC1CCN(CC1)C2=C3C=C(OC)C(OC)=CC3=NC(N)=N2)=O
Molecular Formula
C17H26N6O4S
Molecular Weight
410.49
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD100 (Semaphorin-4D) (A8), CF640R conjugate, 0.1mg/mL
Human IgG Immunoglobulin (IG266), CF640R conjugate, 0.1mg/mL
CD44 Standard (156-3C11), CF647 conjugate, 0.1mg/mL
P21 / WAF1 (WA-1), CF640R conjugate, 0.1mg/mL
Cytokeratin 17 (E3), CF640R conjugate, 0.1mg/mL
